Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients

NeuroImage
Pilar Salgado-PinedaMiquel Bernardo

Abstract

Impaired sustained attention seems to be a specific neuropsychological deficit that is closely linked to schizophrenia. Voxel based morphometry has emerged as a useful tool for the detection of subtle gray matter (GM) abnormalities. The aim of our study was to identify the cerebral regions related to the Identical-Pair version of the Continuous Performance Test (CPT-IP) performance in schizophrenic patients. The study included 13 right-handed, male, first-episode, paranoic, neuroleptic-naive schizophrenic patients and 13 matched controls. High-resolution whole-brain MR images were segmented and analyzed for the whole brain and for regions of interest (ROI) using SPM99. Furthermore, the correlation between CPT-IP performance and GM density was examined. Volumetric analysis of the thalami was also carried out. GM density analysis shown decreases in patients in anterior cingulate gyrus, left inferior frontal, right claustrum, left pulvinar, and dorsomedial bilateral thalamic nuclei, and caudate nuclei as well as left hippocampus and parahippocampal gyrus. Thalamic ROIs revealed a strong correlation between groups differences. The thalamic GM density allowed a good individual classification. GM increases were detected in left insul...Continue Reading

References

Dec 1, 1992·Archives of General Psychiatry·M S BuchsbaumP A Jerabek
Jan 1, 1990·Annual Review of Neuroscience·M I Posner, S E Petersen
Jan 1, 1995·Schizophrenia Bulletin·A F MirskyM Nathan
Jan 1, 1994·Schizophrenia Bulletin·B A Cornblatt, J G Keilp
Oct 1, 1993·Neuropathology and Applied Neurobiology·B Pakkenberg
Jun 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·M Cannon, P Jones
Jan 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G D PearlsonA Y Tien
Feb 16, 1999·Schizophrenia Research·I C WrightP K McGuire
Oct 26, 1999·Development and Psychopathology·B CornblattL Erlenmeyer-Kimling
Nov 26, 1999·European Psychiatry : the Journal of the Association of European Psychiatrists·H VolzH Sauer
Feb 29, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S K LiuH N Lin
Mar 4, 2000·The American Journal of Psychiatry·M NiznikiewiczM E Shenton
Jun 6, 2000·Biological Psychiatry·K A YoungD C German
Jul 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·G J PopkenE G Jones
Jul 27, 2000·The American Journal of Psychiatry·M F EganD R Weinberger
Nov 22, 2000·Schizophrenia Bulletin·G Stanghellini
Feb 13, 2001·Biological Psychiatry·L C Konick, L Friedman
May 10, 2001·Schizophrenia Research·M E ShentonR W McCarley
Jun 27, 2001·American Journal of Medical Genetics·B A Cornblatt, A K Malhotra
Jan 5, 2002·The American Journal of Psychiatry·William ByneLiesl Jones
Oct 1, 1956·Journal of Consulting Psychology·L H BECKI SARASON

❮ Previous
Next ❯

Citations

Jul 8, 2008·Acta Neuropathologica·William ByneEileen Kemether
Oct 28, 2005·Journal of Neural Transmission·K SimS Heckers
May 14, 2005·Journal of Psychiatric Research·Róbert Bódizs, Alpár Sándor Lázár
Jan 21, 2010·Psychological Medicine·J Moncrieff, J Leo
Feb 28, 2008·Cognitive Neuropsychiatry·Maria-Giovanna DucatoMuriel Boucart
Nov 18, 2011·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Kyoung-Hwan RheuSabina Lim
Aug 12, 2008·Schizophrenia Bulletin·Dwight Dickinson, Philip D Harvey
Nov 15, 2011·Schizophrenia Bulletin·Paolo Fusar-PoliStefan Borgwardt
Sep 11, 2009·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Raymond C K ChanQiyong Gong
Jun 21, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·S D GaleS C Johnson
Feb 27, 2010·Journal of Psychiatry & Neuroscience : JPN·Bjørn H EbdrupWilliam Baaré
Mar 17, 2005·The Heart Surgery Forum·Donald S LikoskyGerald T O'Connor
Feb 23, 2010·Indian Journal of Psychiatry·Ganesan Venkatasubramanian
Feb 25, 2014·Neuroradiology·Sadhana SinghSubash Khushu
Sep 25, 2012·BMC Psychiatry·Gricel OrellanaMarcela Peña
Mar 2, 2005·Journal of Clinical Psychopharmacology·Guillem MassanaMiquel Bernardo
Feb 24, 2006·Molecular Psychiatry·D ClarkI Matsumoto
Feb 26, 2016·Frontiers in Cellular Neuroscience·Katarina DavalievaAndrew J Dwork
Sep 10, 2010·Schizophrenia Research·Nikolaos KoutsoulerisEva M Meisenzahl
Jun 16, 2010·Schizophrenia Research·Giuseppina RamettiMiguel Bernardo
Dec 1, 2009·The Psychiatric Clinics of North America·Arman Danielyan, Henry A Nasrallah
Jan 15, 2010·Schizophrenia Research·Ian Ellison-Wright, Ed Bullmore
Apr 25, 2008·European Psychiatry : the Journal of the Association of European Psychiatrists·Robert Christian WolfNenad Vasic
Oct 4, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·H KleinlogelS Begré

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here